Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer
Skin cancer, which includes melanoma and squamous cell carcinoma, represents the most common type of cutaneous malignancy worldwide, and its incidence is expected to rise in the near future. This condition derives from acquired genetic dysregulation of signaling pathways involved in the proliferatio...
Main Authors: | Fatemeh Bootorabi, Hamed Manouchehri, Reza Changizi, Harlan Barker, Elisabetta Palazzo, Annalisa Saltari, Mataleena Parikka, Carlo Pincelli, Ashok Aspatwar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/7/1550 |
Similar Items
-
Overexpression of Notch Signaling Induces Hyperosteogeny in Zebrafish
by: Sung-Tzu Liang, et al.
Published: (2019-07-01) -
Gut micobiota alteration by Lactobacillus rhamnosus reduces pro-inflammatory cytokines and glucose level in the adult model of Zebrafish
by: Fatemeh Bootorabi, et al.
Published: (2021-08-01) -
In vitro inhibition of Mycobacterium tuberculosis β-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos
by: Ashok Aspatwar, et al.
Published: (2020-01-01) -
Transgenic fluorescent zebrafish lines that have revolutionized biomedical research
by: Chong Pyo Choe, et al.
Published: (2021-09-01) -
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes
by: Ashok Aspatwar, et al.
Published: (2018-01-01)